Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jan 31, 2025 | (Q2)Jul 31, 2024 | (Q1)Apr 30, 2024 | (FY)Jan 31, 2024 | (Q4)Jan 31, 2024 | (Q3)Oct 31, 2023 | (Q2)Jul 31, 2023 | (Q1)Apr 30, 2023 | (FY)Jan 31, 2023 | (Q4)Jan 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 23.20%16.67B | 27.37%4.44B | 32.32%3.86B | 26.17%13.53B | 22.18%3.84B | 33.69%3.29B | 21.34%3.49B | 2.92B | 51.59%10.72B | 3.14B |
| Cost of revenue | 15.71%3.52B | 14.96%922M | 30.90%843M | 21.29%3.04B | 20.71%851M | 22.33%745M | 25.51%802M | 644M | 57.74%2.51B | 705M |
| Gross profit | 25.37%13.15B | 31.10%3.52B | 32.67%3.02B | 27.66%10.49B | 22.66%2.99B | 37.37%2.54B | 20.11%2.68B | 2.27B | 49.82%8.21B | 2.44B |
| Operating expense | 15.21%7.82B | 18.82%1.96B | 20.20%1.82B | 13.35%6.79B | 18.70%1.97B | 17.54%1.66B | 10.31%1.65B | 1.52B | 37.55%5.99B | 1.66B |
| Selling and administrative expenses | 16.98%7.83B | 19.53%1.97B | 20.13%1.83B | 11.54%6.69B | 13.93%1.87B | 16.35%1.65B | 9.82%1.64B | --1.52B | 34.67%6B | --1.64B |
| -General and administrative expense | 16.98%7.83B | 19.53%1.97B | 20.13%1.83B | 11.54%6.69B | 13.93%1.87B | 16.35%1.65B | 9.82%1.64B | --1.52B | 34.67%6B | --1.64B |
| Other operating expenses | -80.00%23M | -25.00%3M | --1M | 945.45%115M | --103M | --8M | --4M | ---- | -8.33%11M | ---- |
| Total other operating income | 63.16%31M | 1,000.00%11M | 20.00%6M | -13.64%19M | 366.67%8M | -63.64%4M | -75.00%1M | --5M | -80.53%22M | ---3M |
| Operating profit | 44.00%5.33B | 50.63%1.56B | 57.58%1.2B | 66.14%3.7B | 31.11%1.02B | 100.68%885M | 39.86%1.04B | 759M | 97.08%2.23B | 778M |
| Net non-operating interest income (expenses) | -2.72%-416M | -67.29%-179M | 11.43%-93M | 56.03%-405M | 76.13%-90M | 45.45%-102M | 39.20%-107M | -105M | -49.76%-921M | -377M |
| Non-operating interest income | 25.00%5M | 0.00%1M | --1M | --4M | --2M | --1M | --1M | --0 | --0 | --0 |
| Non-operating interest expense | 2.93%421M | 66.67%180M | -10.48%94M | -55.59%409M | -75.60%92M | -44.92%103M | -38.64%108M | --105M | 49.76%921M | --377M |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | ||||||||||
| Other non-operating income (expenses) | ||||||||||
| Income before tax | 49.07%4.91B | 48.87%1.38B | 68.50%1.1B | 152.49%3.3B | 131.92%930M | 209.49%783M | 64.36%927M | 654M | 153.40%1.31B | 401M |
| Income tax | -1.61%917M | 131.58%440M | 1.67%365M | 30.72%932M | -27.56%113M | 42.33%269M | -33.33%190M | 359M | 117.38%713M | 156M |
| Net income | 69.09%3.99B | 27.54%940M | 150.34%736M | 299.66%2.36B | 233.06%816M | 715.87%514M | 164.16%737M | 294M | 217.74%591M | 245M |
| Net income continuous operations | 69.06%4B | 27.54%940M | 149.83%737M | 299.16%2.36B | 233.47%817M | 703.13%514M | 164.16%737M | --295M | 216.58%592M | --245M |
| Noncontrolling interests | 0 | 0 | 0 | -51.34%145M | 0 | 0 | 0 | 145M | 210.42%298M | 123M |
| Net income attributable to the company | 80.15%3.99B | 27.54%940M | 397.30%736M | 659.25%2.22B | 569.67%817M | 1,613.33%514M | 434.06%737M | 148M | 224.44%292M | 122M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 80.15%3.99B | 27.54%940M | 397.30%736M | 659.25%2.22B | 569.67%817M | 1,613.33%514M | 434.06%737M | 148M | 224.44%292M | 122M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 51.24%166.44 | 20.15%39.28 | 138.60%30.76 | 332.66%110.05 | 429.63%34.1209 | 938.66%27.1426 | 348.61%32.6916 | 12.892 | 576.71%25.4355 | 6.4424 |
| Diluted earnings per share | 50.97%163.09 | 18.23%38.41 | 137.96%30.16 | 331.38%108.03 | 534.45%34.1209 | 938.66%27.1426 | 434.06%32.4884 | 12.6745 | 566.26%25.0429 | 5.378 |
| Dividend per share | 247.37%66 | 22 | 0 | 19 | 19 | |||||
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |